Episode 4 - Kelly Collins/ CEO Founder SureAdhere - The story of SureAdhere. We discuss who pays for mHealth solutions, how to improve adoption and more

Kelly Collins/ CEO founder SureAdhere - The story of SureAdhere. We discuss who pays for mHealth solutions, how to improve adoption, how to determine which market to enter with your product, the challenges faced with market expansion and the implications of COVID 19 on mHealth tech.

Show notes:

Sureadhere: http://www.sureadhere.com/

Kelly Collins https://www.linkedin.com/in/kelly-m-collins-813025a7/ 

Directly Observed Therapy (DOT) is a specific strategy, endorsed by the World Health Organization, to improve adherence by requiring health workers, community volunteers or family members to observe and record patients taking each dose.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460720/

Extensively drug-resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin).

https://www.cdc.gov/tb/publications/factsheets/drtb/xdrtb.htm#:~:text=Extensively drug-resistant TB (XDR,%2C kanamycin%2C or capreomycin).

Lemonade claims process

https://www.lemonade.com/claims

https://www.lemonade.com/blog/file-theft-claim/

Involves AI-driven claims processing which sometimes includes video summary of what happened.